Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening

Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening

The NeuMoDx HPV assay is a novel fully automated, real-time PCR-based assay for the qualitative detection of high-risk human papillomavirus (HPV) DNA in cervical specimens. The assay specifically identifies HPV16 and HPV18 and concurrently detects 13 other high-risk HPV types at clinically relevant...

Full description

Bibliographic Details
Main Authors: Daniëlle A. M. Heideman, Anja Oštrbenk Valenčak, Saskia Doorn, Jesper Bonde, Peter Hillemanns, Grega Gimpelj Domjanič, Jana Mlakar, Albertus T. Hesselink, Chris J. L. M. Meijer, Mario Poljak
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Viruses
Subjects:
human papillomavirus
NeuMoDx HPV Test Strip
clinical performance
reproducibility
cervical cancer screening
liquid medium
Online Access:https://www.mdpi.com/1999-4915/14/5/893

Internet

https://www.mdpi.com/1999-4915/14/5/893

Similar Items